Send your comments and tips to email@example.com
Beth Israel Deaconess Medical Ctr.
Boston Medical Center
Brigham and Women's Hospital
Cambridge Health Alliance
Caritas St. Elizabeth's Medical Ctr.
Children's Hospital Boston
Dana-Farber Cancer Institute
Joslin Diabetes Center
Mass. General Hospital
Mass. Health Law
New England Baptist Hospital
Short White Coat
Tufts-New England Medical Center
UMass Memorial Medical Center
University of Massachusetts
VA Medical Centers
A Healthy Blog
Running A Hospital
Nature Network Boston
SciBos - Corie Lok's blog
Nurse at small
Dr. Gwenn Is In
Healthy Children blog
Other Globe Blogs
Elizabeth Cooney is a health reporter for the Worcester Telegram & Gazette.
Boston Globe Health and Science staff:
Karen Weintraub, Deputy Health and Science Editor, and Gideon Gil, Health and Science Editor.
Short White Coat blogger Ishani Ganguli
Short White Coat blogger Jennifer Srygley
Friday, April 13, 2007
Today's Globe: "stuck kids," drug-resistant gonorrhea, disabled veterans, monkey gene map, obesity-risk gene, Arcoxia
The state's mental health system for children is clogged with some of its worst backups in years, leading to long emergency room waits and a record number of "stuck kids" who are deemed well enough to leave hospital units but have nowhere to go.
Antibiotic-resistant gonorrhea is spreading rapidly across the United States, federal health officials reported yesterday, raising alarm about doctors' ability to treat the common sexually transmitted infection.
The Army might be shortchanging injured soldiers by rating the severity of their disabilities with a system that is both unwieldy and inconsistent, the head of a special commission said yesterday.
Scientists have unraveled the DNA of another of our primate relatives, this time a monkey named the rhesus macaque -- and the work has far more immediate impact than just to study evolution.
British researchers have produced the first clear evidence for a gene common in the population that dictates why some people gain excess weight while others do not.
Merck & Co.'s experimental arthritis drug Arcoxia shouldn't be allowed on the US market, a Food and Drug Administration advisory panel said, citing some of the same risks that led to the withdrawal of the similar treatment Vioxx.